1. guilin sanjin (002275): The concept is the most authentic, especially the concept of "precise medical care+anti-cancer" which is most consistent with celator, the hottest in American stocks. Baochuan Bio, a wholly-owned subsidiary holding 100% equity, has been deeply involved in the field of precision medicine for many years, and its core R&D personnel are all Chinese Americans from large well-known pharmaceutical companies. At present, Baochuan Bio has two anti-cancer R&D projects, and the Arbituo project (used to treat metastatic colorectal cancer) and Herceptin project (mainly used to treat some HER-2 positive breast cancer) are the best-selling anti-cancer drugs.
2. New open source (300 109): increase the acquisition of 0/00% equity of Shan Zhi Bio, Hull Medical and Jingneng Bio/kloc. The acquired company mainly does genetic testing.
3. anke biotechnology Science and Technology (300009): 2065438+April 2006, the company plans to acquire 0/00% equity of Sino-German Midland/KLOC for 449.88 million yuan. The business scope of the target company includes bioengineering, biochips, genetically engineered antibodies and drugs, belonging to the field of precision medicine.
4. Qian Shan Pharmaceutical Machinery (3002 16): The individualized drug use of Hong Hao gene, a holding subsidiary, is growing rapidly at present.